Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCI

View source ↗

Summary

Update on an individual patient expanded access IND for Hope Biosciences' autologous adipose-derived mesenchymal stem cells to treat spinal cord injury. The tri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells (autologous adipose-derived mesenchymal stem cells)

Snippet

Sponsor: Hope Biosciences LLC | Conditions: Spinal Cord Injury at C5-C7 Level | Status: NO_LONGER_AVAILABLE